Molecular imaging & imaging-guided therapy

Preclinical and clinical imaging CERIMED platforms

Leader : Pascal BELIN (AMU, CERIMED, INT)

Methodological developments generated by the activity of DHU-Imaging teams will be validated on CERIMED (pre)clinical imaging platforms , and then implemented for hospital, academic, and industrial partners, with the support of OPTITEC and Eurobiomed clusters, to improve deliveries.

The objective of CERIMED imaging platforms is to address cutting-edge scientific issues, as well as to facilitate access to clinical trials and cohort studies. CERIMED is equipped with all (pre)clinical modalities: PET, SPECT, CT-scan, angiography (interventional procedures), US and optical imaging techniques. Moreover, CERIMED provides access to dedicated areas authorized for human and animal experimentations to validate prototypes in comparison to the reference technique.